These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Bath PM; Hassall DG; Gladwin AM; Palmer RM; Martin JF Arterioscler Thromb; 1991; 11(2):254-60. PubMed ID: 1847823 [TBL] [Abstract][Full Text] [Related]
26. A new cGMP phosphodiesterase isolated from bovine platelets is substrate for cAMP- and cGMP-dependent protein kinases: evidence for a key role in the process of platelet activation. Robichon A J Cell Biochem; 1991 Oct; 47(2):147-57. PubMed ID: 1661738 [TBL] [Abstract][Full Text] [Related]
27. Platelet interactions with the endothelium and the subendothelium: the role of thrombin and prostacyclin. Cazenave JP; Dejana E; Kinlough-Rathbone R; Packham MA; Mustard JF Haemostasis; 1979; 8(3-5):183-92. PubMed ID: 389756 [TBL] [Abstract][Full Text] [Related]
28. Platelets, oxidant stress and erectile dysfunction: an hypothesis. Jeremy JY; Angelini GD; Khan M; Mikhailidis DP; Morgan RJ; Thompson CS; Bruckdorfer KR; Naseem KM Cardiovasc Res; 2000 Apr; 46(1):50-4. PubMed ID: 10727652 [No Abstract] [Full Text] [Related]
29. Thrombin induced platelet adhesion to endothelium is modified by endothelial derived relaxing factor (EDRF). Venturini CM; Del Vecchio PJ; Kaplan JE Biochem Biophys Res Commun; 1989 Feb; 159(1):349-54. PubMed ID: 2784317 [TBL] [Abstract][Full Text] [Related]
30. Involvement of cyclic GMP in non-adrenergic, non-cholinergic inhibitory neurotransmission in dog proximal colon. Ward SM; Dalziel HH; Bradley ME; Buxton IL; Keef K; Westfall DP; Sanders KM Br J Pharmacol; 1992 Dec; 107(4):1075-82. PubMed ID: 1334749 [TBL] [Abstract][Full Text] [Related]
31. EDRF increases cyclic GMP in platelets during passage through the coronary vascular bed. Pohl U; Busse R Circ Res; 1989 Dec; 65(6):1798-803. PubMed ID: 2555082 [TBL] [Abstract][Full Text] [Related]
32. Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Doni MG; Whittle BJ; Palmer RM; Moncada S Eur J Pharmacol; 1988 Jun; 151(1):19-25. PubMed ID: 3046956 [TBL] [Abstract][Full Text] [Related]
33. Effects of hypoxia and metabolic inhibitors on production of prostacyclin and endothelium-derived relaxing factor by pig aortic endothelial cells. Richards JM; Gibson IF; Martin W Br J Pharmacol; 1991 Jan; 102(1):203-9. PubMed ID: 1646057 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence. Czervionke RL; Smith JB; Fry GL; Hoak JC; Haycraft DL J Clin Invest; 1979 May; 63(5):1089-92. PubMed ID: 376548 [TBL] [Abstract][Full Text] [Related]
35. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Radomski MW; Palmer RM; Moncada S Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462 [TBL] [Abstract][Full Text] [Related]
36. Effects of prostacyclin analogue (carbacyclin) on the interaction of platelets with different collagen substrates. Inhibition of cAMP increase by collagens type I, III, and IV. Mazurov AV; Misselwitz F; Hoffman U; Leytin VL; Repin VS Prostaglandins; 1988 Jan; 35(1):51-65. PubMed ID: 2836888 [TBL] [Abstract][Full Text] [Related]
37. Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle. Harris AL; Lemp BM; Bentley RG; Perrone MH; Hamel LT; Silver PJ J Pharmacol Exp Ther; 1989 May; 249(2):394-400. PubMed ID: 2566675 [TBL] [Abstract][Full Text] [Related]
38. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin. Macdonald PS; Read MA; Dusting GJ Thromb Res; 1988 Mar; 49(5):437-49. PubMed ID: 3287674 [TBL] [Abstract][Full Text] [Related]